Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $145
Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $145
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $145
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $343
Benchmark Initiates Coverage On Walt Disney with Buy Rating, Announces Price Target of $115
BMO Capital Maintains Outperform on Merck & Co, Raises Price Target to $142
Why Is Intel Stock Falling Monday?
Reported Earlier: 'Saudi Tech Firm NourNet Is Said to Pick Goldman, HSBC for IPO' - Bloomberg
Wells Fargo Maintains Overweight on UnitedHealth Group, Raises Price Target to $485
RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $287
Trump’s Trillion‑Dollar Defense Push Could Be a Boon for Lockheed, RTX, Boeing and Northrop
Oppenheimer Maintains Outperform on Caterpillar, Raises Price Target to $1105
Critical 4 Hours Ahead, Korea And Iran Drive Selling In US Markets
JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $140
Big Bank Earnings Preview: Bank of America, JPMorgan Stocks Starting to Rally — Will This Laggard Be Next?
Shares of foundry, fabricator and IDM chip companies are trading lower due to volatility initiated from South Korea after Samsung and SK Hynix fell, dragging down the KOPSI and U.S…
3 Shipping And Insurance Stocks To Watch As Hormuz Tensions Rise
HSBC Maintains Hold on American Express, Raises Price Target to $329
Quantum Tech on Capitol Hill: Nvidia, IBM and More Stocks to Watch
Forget Interest Rates: Bank Earnings Could Reveal the Next Catalyst for Financial ETFs
Evercore ISI Group Maintains Outperform on Honeywell Intl, Raises Price Target to $275
TD Cowen Maintains Hold on Intel, Raises Price Target to $115